FFA
TXG icon

Farther Finance Advisors’s 10x Genomics TXG Stock Holding History

Farther Finance Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5K Sell
719
-763
-51% -$20K ﹤0.01% 3729
2026
Q1 		$32.7K Buy
1,482
+811
+121% +$16.2K ﹤0.01% 3301
2025
Q4 		$10.9K Buy
671
+244
+57% +$3.69K ﹤0.01% 3847
2025
Q3 		$4.99K Buy
427
+16
+4% +$209 ﹤0.01% 3767
2025
Q2 		$4.76K Buy
411
+99
+32% +$902 ﹤0.01% 3375
2025
Q1 		$2.71K Buy
312
+54
+21% +$681 ﹤0.01% 3271
2024
Q4 		$3.71K Sell
258
-173
-40% -$2.73K ﹤0.01% 2785
2024
Q3 		$9.73K Buy
431
+92
+27% +$1.9K ﹤0.01% 2383
2024
Q2 		$6.3K Sell
339
-29
-8% -$759 ﹤0.01% 2284
2024
Q1 		$13.6K Buy
368
+242
+192% +$10.6K ﹤0.01% 1630
2023
Q4 		$7.05K Buy
126
+33
+35% +$1.44K ﹤0.01% 1791
2023
Q3 		$3.84K Buy
93
+40
+75% +$2.08K ﹤0.01% 1606
2023
Q2 		$2.96K Sell
53
-994
-95% -$53.8K ﹤0.01% 1618
2023
Q1 		$58.4K Buy
+1,047
New +$48.9K 0.02% 563

Other funds holding TXG

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $400M AUM 39.13% 1-Year Est. Return

Farther Finance Advisors's TXG Position: Q2 2026 in Review

Farther Finance Advisors reduced its 10x Genomics (TXG) stake by 51% in Q2 2026, selling an estimated $20K and leaving 719 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3729.

Farther Finance Advisors first reported a position in TXG in Q1 2023 and has held it in 14 quarters since. The position peaked at $58.4K in Q1 2023. 46 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Farther Finance Advisors held 719 shares of 10x Genomics worth $27.5K as of Q2 2026.
  • Farther Finance Advisors sold 763 10x Genomics shares in Q2 2026, an estimated $20K.
  • 10x Genomics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3729 holding.
  • Farther Finance Advisors first reported a position in 10x Genomics in Q1 2023 and has held it in 14 quarters since.
  • Farther Finance Advisors's 10x Genomics position peaked at $58.4K in Q1 2023.
  • 46 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.